NCT01530269View on ClinicalTrials.gov

C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Prostate CancerProstate Adenocarcinoma
Interventions
DRUG

C11-Sodium Acetate

PET Imaging with C11-Sodium Acetate

Trial Locations (1)

85040

Phoenix Molecular Imaging, Phoenix

Sponsors
All Listed Sponsors
lead

Phoenix Molecular Imaging

OTHER